Want to join the conversation?
$BIIB said it is preparing to launch Zinbryta in Aug. 2016 in the US and Germany. Zinbryta is the first in a new class of multiple sclerosis therapy. The company added that Zinbryta will be used by patients switching for efficacy reasons, benefiting from once monthly at home subcutaneous administration and a differentiated mechanism of action.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!